CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1
Xiangnan Du(Beijing Luhe Hospital Affiliated to Capital Medical University), Eugene Y. Chiang(Gene Therapy Laboratory), Vidhyalakshmi Arumugam, Thomas D. Wu, Keith R. Anderson(Genesys (United States)), Denise de Almeida Nagata, Kristin Harden Bowles(Cancer Research Institute), Patrícia de Almeida, Søren Warming(Genesys (United States)), Rafael Cubas(Theravance Biopharma (United States)), Nick Manieri, Stephanie Mittman(Translational Research in Oncology), Jane L. Grogan(Biogen (United States)), Jill Schartner(University of Wisconsin–Madison), Vincent Javinal
Cited by 63
Related Papers
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
|Nature Immunology|2008|1.5k
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
|Cancer Cell|2014|1.1k
IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines
|Nature Immunology|2022|529
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
|Cancer Cell|2022|403
Inadequate T follicular cell help impairs B cell immunity during HIV infection
|Nature Medicine|2013|362